CANESTEN 6 DAY INTERNAL CREAM

Country: Canada

Language: English

Source: Health Canada

Active ingredient:

CLOTRIMAZOLE

Available from:

BAYER INC

ATC code:

G01AF02

INN (International Name):

CLOTRIMAZOLE

Dosage:

1%

Pharmaceutical form:

CREAM

Composition:

CLOTRIMAZOLE 1%

Administration route:

VAGINAL

Units in package:

50G

Prescription type:

OTC

Therapeutic area:

AZOLES

Product summary:

Active ingredient group (AIG) number: 0110231001; AHFS:

Authorization status:

APPROVED

Authorization date:

2008-01-02

Summary of Product characteristics

_ _
_Canesten® Page 1 of 38_
PRODUCT MONOGRAPH
CANESTEN® 6 DAY INTERNAL CREAM
1% Clotrimazole Vaginal Cream, Bayer Std.
CANESTEN® 3 DAY INTERNAL CREAM
2% Clotrimazole Vaginal Cream, Bayer Std.
CANESTEN® 1 DAY INTERNAL CREAM
10% Clotrimazole Vaginal Cream, Bayer Std.
CANESTEN® COMBI 1 DAY INTERNAL + EXTERNAL CREAMS
10% & 1% Clotrimazole Vaginal Cream, Bayer Std.
CANESTEN COMFORTAB 1
500mg Clotrimazole Vaginal Tablet, BP Std.
CANESTEN COMFORTAB 3
200mg Clotrimazole Vaginal Tablets, BP Std.
CANESTEN® COMBI 1 DAY
500mg Clotrimazole Vaginal Tablet, BP Std.
1% Clotrimazole Cream, Bayer Std.
CANESTEN® COMBI 3 DAY
200mg Clotrimazole Vaginal Tablets, BP Std.
1% Clotrimazole Cream, Bayer Std.
CANESTEN® EXTERNAL CREAM
1% Clotrimazole Cream, Bayer Std.
CANESTEN® EXTERNAL ANTIFUNGAL CREAM
1% Clotrimazole Cream, Bayer Std.
CANESTEN® EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM
2% Clotrimazole Cream, Bayer Std
(Clotrimazole) Bayer Standard
Antifungal Agent
Bayer Inc.
2920 Matheson Boulevard East
Mississauga, Ontario
L4W 5R6
Control No.: 254158
Date of Preparation:
September 30
th
, 2015
Date of Revision:
January 6
th
, 2022
_ _
_Canesten® Page 2 of 38_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
..................................................... 3
SUMMARY PRODUCT INFORMATION
...............................................................................
3
INDICATIONS AND CLINICAL USE
.....................................................................................
3
CONTRAINDICATIONS
..........................................................................................................
4
WARNINGS AND PRECAUTIONS
.........................................................................................
4
ADVERSE REACTIONS
...........................................................................................................
5
DRUG INTERACTIONS
...........................................................................................................
6
DOSAGE AND ADMINISTRATION
..................